Escalating Middle East conflict and rising bond yields weigh on Wall Street and heighten inflation concerns Uncertainty dominates the global financial markets, causing the major New York indices to start Friday's trading weakly. While the leading index Dow Jones is down 0.7% at 45,700 points, the S&P 500 drops 0.81% to 6546 points, approaching...
The Best Growth Stocks by Revenue Growth
Stocks with high revenue growth on a TTM basis, sorted by distance to the 52-week high.
| Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
|---|---|---|---|---|---|
| WKN | Symbol | EPS Growth | Rel. Strength | |||
| 1 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
| A2PHB6 | PLMR | 49.48 % | 96 | |||
| 2 | HCI Group | 137.20 $ | 49.16 % | 9.67 % | -1.52 % |
| A1W02H | HCI | 199.39 % | 85 | |||
| 3 | Alignment Healthcare | 18.84 $ | 48.25 % | 10.54 % | 19.92 % |
| A2QSBM | ALHC | - % | 99 | |||
| 4 | HEICO | 187.93 $ | 43.13 % | 14.27 % | -5.63 % |
| 914043 | HEI/A | 19.31 % | 87 | |||
| 5 | Heico | 238.62 $ | 43.13 % | 15.86 % | -5.58 % |
| 889997 | HEI | 19.31 % | 88 | |||
| 6 | StoneX Group | 70.30 $ | 64.14 % | 17.76 % | -3.65 % |
| A2P8CE | SNEX | 7.01 % | 95 | |||
| 7 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
| A0LCUL | CPRX | 111.86 % | 90 | |||
| 8 | Newmont | 46.64 $ | 53.66 % | 20.57 % | 6.90 % |
| 853823 | NEM | - % | 83 | |||
| 9 | Rhythm Pharmaceuticals | 53.57 $ | 81.55 % | 21.89 % | 4.38 % |
| A2H5A0 | RYTM | - % | 87 | |||
| 10 | Mercadolibre | 1,842.40 $ | 43.63 % | 22.44 % | -8.13 % |
| A0MYNP | MELI | 43.98 % | 86 | |||
Subscribe now to see the full ranking
Already a subscriber? Login
Sample Issue
$
0
one issue
Bestseller
Trial Subscription
$
33
1 month
Bayer AG [DE000BAY0017] ODDO BHF upgrades from "Neutral" to "Outperform" and raises the price target from €39.80 to €55.00 (37% upside potential) Analyst Stephan Wulf expects upward momentum for Bayer shares from several directions. Most crucially for him, the end of the long-running glyphosate litigations appears to be in sight. As this burden...